×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Japan Morphine Market

ID: MRFR/HC/49740-HCR
200 Pages
MRFR Team
May 2025

Japan Morphine Market Research Report: By Dosage Form (Injection, Oral, Other Dosage Forms), By Application (Pain Management, Diarrhea Suppressant, Cold & Cough Suppressant, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) andBy End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others)- Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Options

Japan Morphine Market Summary

Industry Developments

The Japan Morphine Market has seen noteworthy developments recently, particularly amid a growing focus on pain management solutions. Eisai Co and Takeda Pharmaceutical Company continue to innovate in this space, contributing to the market’s growth dynamics. Current affairs indicate a shift towards enhancing the regulatory framework surrounding opioid medications, with the Japanese government implementing stricter measures to prevent misuse, impacting companies like Johnson and Johnson and Otsuka Pharmaceutical. In the last few years, significant movements were noted, such as the collaboration between Bristol-Myers Squibb and Astellas Pharma in 2022, aimed at enhancing Research and Development capacities for chronic pain management. As of October 2023, Roche Japan has launched a new morphine variant, which they claim offers improved efficacy for patients. The market valuation of companies like Pfizer Japan and Mitsubishi Tanabe Pharma continues to grow, attributed to the increasing prevalence of chronic pain conditions, thus influencing the overall market landscape. The persistent competitive environment is marked by ongoing improvements in product offerings, which are essential for addressing patient needs in an evolving healthcare system in Japan while adhering to new regulatory standards.

Leave a Comment

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions